Product approval information is indicated for:
•Use as an adjunct to hemostasis in adult and pediatric patients (>1 month of age) undergoing surgery when control of bleeding by conventional surgical techniques (such as suture, ligature, and cautery) is ineffective or impractical.
•An adjunct to sta
via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/L5cw9fb
No comments:
Post a Comment